You appear to be offline. Some data may be unavailable until your connection is restored.

DHR

Stock

Danaher Corporation

Create price alert

Description

Danaher Corporation is a diversified industrial and healthcare conglomerate that designs, manufactures, and markets scientific and medical instruments, consumables, software, and related services. It operates primarily through three segments—Biotechnology, Life Sciences, and Diagnostics—providing tools such as bioprocessing equipment, analytical instruments, clinical testing platforms, and the reagents needed to run them. The company’s business model combines high‑margin equipment sales with recurring revenue from consumables, maintenance contracts, and software, driven by its proprietary Danaher Business System of continuous improvement. Danaher is a leading supplier to pharmaceutical, biotechnology, academic, and clinical customers worldwide and is a prominent component of the S&P 500 health‑care sector.

Quarterly Earnings

QuarterDateEPS
Q2 FY26Jul 21, 2026
Q1 FY26Apr 21, 2026$2.06
Q4 FY25Jan 28, 2026$2.23
Q3 FY25Oct 21, 2025$1.89
Q2 FY25Jul 22, 2025$1.80

Stay ahead of DHR earnings

Get reminders ahead of DHR's next earnings report, so you always know when results are coming.